ボツリヌス毒素＆HA皮膚充填剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Botulinum Toxin & HA Dermal Filler Market Insights, Forecast to 2028

• レポートコード：QY2203B06185 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のボツリヌス毒素＆HA皮膚充填剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にボツリヌス毒素＆HA皮膚充填剤の世界市場のxxx％を占める「ボツリヌス毒素」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「男性用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のボツリヌス毒素＆HA皮膚充填剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのボツリヌス毒素＆HA皮膚充填剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのボツリヌス毒素＆HA皮膚充填剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ボツリヌス毒素＆HA皮膚充填剤のグローバル主要メーカーには、Allergan、Ipsen、Shanghai Haohai Biological Technology、Medytoxなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ボツリヌス毒素＆HA皮膚充填剤市場は、種類と用途によって区分されます。世界のボツリヌス毒素＆HA皮膚充填剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ボツリヌス毒素、HA皮膚充填剤 【用途別セグメント】 男性用、女性用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ボツリヌス毒素＆HA皮膚充填剤製品概要 - 種類別市場（ボツリヌス毒素、HA皮膚充填剤） - 用途別市場（男性用、女性用） - 調査の目的 ・エグゼクティブサマリー - 世界のボツリヌス毒素＆HA皮膚充填剤販売量予測2017-2028 - 世界のボツリヌス毒素＆HA皮膚充填剤売上予測2017-2028 - ボツリヌス毒素＆HA皮膚充填剤の地域別販売量 - ボツリヌス毒素＆HA皮膚充填剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ボツリヌス毒素＆HA皮膚充填剤販売量 - 主要メーカー別ボツリヌス毒素＆HA皮膚充填剤売上 - 主要メーカー別ボツリヌス毒素＆HA皮膚充填剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ボツリヌス毒素、HA皮膚充填剤） - ボツリヌス毒素＆HA皮膚充填剤の種類別販売量 - ボツリヌス毒素＆HA皮膚充填剤の種類別売上 - ボツリヌス毒素＆HA皮膚充填剤の種類別価格 ・用途別市場規模（男性用、女性用） - ボツリヌス毒素＆HA皮膚充填剤の用途別販売量 - ボツリヌス毒素＆HA皮膚充填剤の用途別売上 - ボツリヌス毒素＆HA皮膚充填剤の用途別価格 ・北米市場 - 北米のボツリヌス毒素＆HA皮膚充填剤市場規模（種類別、用途別） - 主要国別のボツリヌス毒素＆HA皮膚充填剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのボツリヌス毒素＆HA皮膚充填剤市場規模（種類別、用途別） - 主要国別のボツリヌス毒素＆HA皮膚充填剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のボツリヌス毒素＆HA皮膚充填剤市場規模（種類別、用途別） - 主要国別のボツリヌス毒素＆HA皮膚充填剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のボツリヌス毒素＆HA皮膚充填剤市場規模（種類別、用途別） - 主要国別のボツリヌス毒素＆HA皮膚充填剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのボツリヌス毒素＆HA皮膚充填剤市場規模（種類別、用途別） - 主要国別のボツリヌス毒素＆HA皮膚充填剤市場規模（トルコ、サウジアラビア） ・企業情報 Allergan、Ipsen、Shanghai Haohai Biological Technology、Medytox ・産業チェーン及び販売チャネル分析 - ボツリヌス毒素＆HA皮膚充填剤の産業チェーン分析 - ボツリヌス毒素＆HA皮膚充填剤の原材料 - ボツリヌス毒素＆HA皮膚充填剤の生産プロセス - ボツリヌス毒素＆HA皮膚充填剤の販売及びマーケティング - ボツリヌス毒素＆HA皮膚充填剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ボツリヌス毒素＆HA皮膚充填剤の産業動向 - ボツリヌス毒素＆HA皮膚充填剤のマーケットドライバー - ボツリヌス毒素＆HA皮膚充填剤の課題 - ボツリヌス毒素＆HA皮膚充填剤の阻害要因 ・主な調査結果

Botulinum Toxin (Botox or BTX) is a poisonous natural protein, created by the bacteria named Clostridium Botulinum. Generally, botulinum toxin is used by the surgeons to obstruct the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction. According to the exotoxins, botulinum toxin can be classified into eight product types including botulinum toxin A, B, C1, D, E, F, G and H.
Market Analysis and Insights: Global Botulinum Toxin & HA Dermal Filler Market
Due to the COVID-19 pandemic, the global Botulinum Toxin & HA Dermal Filler market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Botulinum Toxin accounting for % of the Botulinum Toxin & HA Dermal Filler global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Men segment is altered to an % CAGR throughout this forecast period.
The U.S. emerged as a major region for the botulinum toxin and HA dermal fillers market, due to increased demand for minimally invasive or non-invasive facial cosmetic procedures by the residents of the U.S. supported by growth in their respective disposable income and increased tertiary health care concerns with the development of ageing symptoms.
Global Botulinum Toxin & HA Dermal Filler Scope and Segment
Botulinum Toxin & HA Dermal Filler market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Botulinum Toxin & HA Dermal Filler market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Botulinum Toxin
HA Dermal Filler
Segment by Application
Men
Women
By Company
Allergan
Ipsen
Shanghai Haohai Biological Technology
Medytox
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Botulinum Toxin & HA Dermal Filler Product Introduction
1.2 Market by Type
1.2.1 Global Botulinum Toxin & HA Dermal Filler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Botulinum Toxin
1.2.3 HA Dermal Filler
1.3 Market by Application
1.3.1 Global Botulinum Toxin & HA Dermal Filler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Botulinum Toxin & HA Dermal Filler Sales Estimates and Forecasts 2017-2028
2.2 Global Botulinum Toxin & HA Dermal Filler Revenue Estimates and Forecasts 2017-2028
2.3 Global Botulinum Toxin & HA Dermal Filler Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Botulinum Toxin & HA Dermal Filler Sales by Region
2.4.1 Global Botulinum Toxin & HA Dermal Filler Sales by Region (2017-2022)
2.4.2 Global Sales Botulinum Toxin & HA Dermal Filler by Region (2023-2028)
2.5 Global Botulinum Toxin & HA Dermal Filler Revenue by Region
2.5.1 Global Botulinum Toxin & HA Dermal Filler Revenue by Region (2017-2022)
2.5.2 Global Botulinum Toxin & HA Dermal Filler Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Botulinum Toxin & HA Dermal Filler Sales by Manufacturers
3.1.1 Global Top Botulinum Toxin & HA Dermal Filler Manufacturers by Sales (2017-2022)
3.1.2 Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Botulinum Toxin & HA Dermal Filler in 2021
3.2 Global Botulinum Toxin & HA Dermal Filler Revenue by Manufacturers
3.2.1 Global Botulinum Toxin & HA Dermal Filler Revenue by Manufacturers (2017-2022)
3.2.2 Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxin & HA Dermal Filler Revenue in 2021
3.3 Global Botulinum Toxin & HA Dermal Filler Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Botulinum Toxin & HA Dermal Filler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Botulinum Toxin & HA Dermal Filler Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Botulinum Toxin & HA Dermal Filler Sales by Type
4.1.1 Global Botulinum Toxin & HA Dermal Filler Historical Sales by Type (2017-2022)
4.1.2 Global Botulinum Toxin & HA Dermal Filler Forecasted Sales by Type (2023-2028)
4.1.3 Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
4.2 Global Botulinum Toxin & HA Dermal Filler Revenue by Type
4.2.1 Global Botulinum Toxin & HA Dermal Filler Historical Revenue by Type (2017-2022)
4.2.2 Global Botulinum Toxin & HA Dermal Filler Forecasted Revenue by Type (2023-2028)
4.2.3 Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
4.3 Global Botulinum Toxin & HA Dermal Filler Price by Type
4.3.1 Global Botulinum Toxin & HA Dermal Filler Price by Type (2017-2022)
4.3.2 Global Botulinum Toxin & HA Dermal Filler Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Botulinum Toxin & HA Dermal Filler Sales by Application
5.1.1 Global Botulinum Toxin & HA Dermal Filler Historical Sales by Application (2017-2022)
5.1.2 Global Botulinum Toxin & HA Dermal Filler Forecasted Sales by Application (2023-2028)
5.1.3 Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
5.2 Global Botulinum Toxin & HA Dermal Filler Revenue by Application
5.2.1 Global Botulinum Toxin & HA Dermal Filler Historical Revenue by Application (2017-2022)
5.2.2 Global Botulinum Toxin & HA Dermal Filler Forecasted Revenue by Application (2023-2028)
5.2.3 Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
5.3 Global Botulinum Toxin & HA Dermal Filler Price by Application
5.3.1 Global Botulinum Toxin & HA Dermal Filler Price by Application (2017-2022)
5.3.2 Global Botulinum Toxin & HA Dermal Filler Price Forecast by Application (2023-2028)
6 North America
6.1 North America Botulinum Toxin & HA Dermal Filler Market Size by Type
6.1.1 North America Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2028)
6.1.2 North America Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2028)
6.2 North America Botulinum Toxin & HA Dermal Filler Market Size by Application
6.2.1 North America Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2028)
6.2.2 North America Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2028)
6.3 North America Botulinum Toxin & HA Dermal Filler Market Size by Country
6.3.1 North America Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2028)
6.3.2 North America Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Botulinum Toxin & HA Dermal Filler Market Size by Type
7.1.1 Europe Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2028)
7.1.2 Europe Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2028)
7.2 Europe Botulinum Toxin & HA Dermal Filler Market Size by Application
7.2.1 Europe Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2028)
7.2.2 Europe Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2028)
7.3 Europe Botulinum Toxin & HA Dermal Filler Market Size by Country
7.3.1 Europe Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2028)
7.3.2 Europe Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Botulinum Toxin & HA Dermal Filler Market Size by Type
8.1.1 Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2028)
8.1.2 Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2028)
8.2 Asia Pacific Botulinum Toxin & HA Dermal Filler Market Size by Application
8.2.1 Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2028)
8.2.2 Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2028)
8.3 Asia Pacific Botulinum Toxin & HA Dermal Filler Market Size by Region
8.3.1 Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Region (2017-2028)
8.3.2 Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Botulinum Toxin & HA Dermal Filler Market Size by Type
9.1.1 Latin America Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2028)
9.1.2 Latin America Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2028)
9.2 Latin America Botulinum Toxin & HA Dermal Filler Market Size by Application
9.2.1 Latin America Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2028)
9.2.2 Latin America Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2028)
9.3 Latin America Botulinum Toxin & HA Dermal Filler Market Size by Country
9.3.1 Latin America Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2028)
9.3.2 Latin America Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Botulinum Toxin & HA Dermal Filler Market Size by Type
10.1.1 Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2028)
10.1.2 Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2028)
10.2 Middle East and Africa Botulinum Toxin & HA Dermal Filler Market Size by Application
10.2.1 Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2028)
10.2.2 Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2028)
10.3 Middle East and Africa Botulinum Toxin & HA Dermal Filler Market Size by Country
10.3.1 Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2028)
10.3.2 Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Botulinum Toxin & HA Dermal Filler Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Ipsen
11.2.1 Ipsen Corporation Information
11.2.2 Ipsen Overview
11.2.3 Ipsen Botulinum Toxin & HA Dermal Filler Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ipsen Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ipsen Recent Developments
11.3 Shanghai Haohai Biological Technology
11.3.1 Shanghai Haohai Biological Technology Corporation Information
11.3.2 Shanghai Haohai Biological Technology Overview
11.3.3 Shanghai Haohai Biological Technology Botulinum Toxin & HA Dermal Filler Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shanghai Haohai Biological Technology Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shanghai Haohai Biological Technology Recent Developments
11.4 Medytox
11.4.1 Medytox Corporation Information
11.4.2 Medytox Overview
11.4.3 Medytox Botulinum Toxin & HA Dermal Filler Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medytox Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medytox Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Botulinum Toxin & HA Dermal Filler Industry Chain Analysis
12.2 Botulinum Toxin & HA Dermal Filler Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Botulinum Toxin & HA Dermal Filler Production Mode & Process
12.4 Botulinum Toxin & HA Dermal Filler Sales and Marketing
12.4.1 Botulinum Toxin & HA Dermal Filler Sales Channels
12.4.2 Botulinum Toxin & HA Dermal Filler Distributors
12.5 Botulinum Toxin & HA Dermal Filler Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Botulinum Toxin & HA Dermal Filler Industry Trends
13.2 Botulinum Toxin & HA Dermal Filler Market Drivers
13.3 Botulinum Toxin & HA Dermal Filler Market Challenges
13.4 Botulinum Toxin & HA Dermal Filler Market Restraints
14 Key Findings in The Global Botulinum Toxin & HA Dermal Filler Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Botulinum Toxin & HA Dermal Filler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Botulinum Toxin
Table 3. Major Manufacturers of HA Dermal Filler
Table 4. Global Botulinum Toxin & HA Dermal Filler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Botulinum Toxin & HA Dermal Filler Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Botulinum Toxin & HA Dermal Filler Sales by Region (2017-2022) & (K Units)
Table 7. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Region (2017-2022)
Table 8. Global Botulinum Toxin & HA Dermal Filler Sales by Region (2023-2028) & (K Units)
Table 9. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Region (2023-2028)
Table 10. Global Botulinum Toxin & HA Dermal Filler Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Region (2017-2022)
Table 12. Global Botulinum Toxin & HA Dermal Filler Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Region (2023-2028)
Table 14. Global Botulinum Toxin & HA Dermal Filler Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Botulinum Toxin & HA Dermal Filler Sales Share by Manufacturers (2017-2022)
Table 16. Global Botulinum Toxin & HA Dermal Filler Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Botulinum Toxin & HA Dermal Filler Revenue Share by Manufacturers (2017-2022)
Table 18. Botulinum Toxin & HA Dermal Filler Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Botulinum Toxin & HA Dermal Filler Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Botulinum Toxin & HA Dermal Filler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxin & HA Dermal Filler as of 2021)
Table 21. Botulinum Toxin & HA Dermal Filler Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Botulinum Toxin & HA Dermal Filler Product Offered
Table 23. Date of Manufacturers Enter into Botulinum Toxin & HA Dermal Filler Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 26. Global Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 27. Global Botulinum Toxin & HA Dermal Filler Sales Share by Type (2017-2022)
Table 28. Global Botulinum Toxin & HA Dermal Filler Sales Share by Type (2023-2028)
Table 29. Global Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Botulinum Toxin & HA Dermal Filler Revenue Share by Type (2017-2022)
Table 32. Global Botulinum Toxin & HA Dermal Filler Revenue Share by Type (2023-2028)
Table 33. Botulinum Toxin & HA Dermal Filler Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Botulinum Toxin & HA Dermal Filler Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 36. Global Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 37. Global Botulinum Toxin & HA Dermal Filler Sales Share by Application (2017-2022)
Table 38. Global Botulinum Toxin & HA Dermal Filler Sales Share by Application (2023-2028)
Table 39. Global Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Botulinum Toxin & HA Dermal Filler Revenue Share by Application (2017-2022)
Table 42. Global Botulinum Toxin & HA Dermal Filler Revenue Share by Application (2023-2028)
Table 43. Botulinum Toxin & HA Dermal Filler Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Botulinum Toxin & HA Dermal Filler Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 46. North America Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 47. North America Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 50. North America Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 51. North America Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2022) & (K Units)
Table 54. North America Botulinum Toxin & HA Dermal Filler Sales by Country (2023-2028) & (K Units)
Table 55. North America Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Botulinum Toxin & HA Dermal Filler Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 58. Europe Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 59. Europe Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 62. Europe Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 63. Europe Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2022) & (K Units)
Table 66. Europe Botulinum Toxin & HA Dermal Filler Sales by Country (2023-2028) & (K Units)
Table 67. Europe Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Botulinum Toxin & HA Dermal Filler Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Botulinum Toxin & HA Dermal Filler Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Botulinum Toxin & HA Dermal Filler Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue by Country (2023-2028) & (US$ Million)
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Major Businesses
Table 107. Allergan Botulinum Toxin & HA Dermal Filler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Allergan Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Allergan Recent Developments
Table 110. Ipsen Corporation Information
Table 111. Ipsen Description and Major Businesses
Table 112. Ipsen Botulinum Toxin & HA Dermal Filler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Ipsen Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Ipsen Recent Developments
Table 115. Shanghai Haohai Biological Technology Corporation Information
Table 116. Shanghai Haohai Biological Technology Description and Major Businesses
Table 117. Shanghai Haohai Biological Technology Botulinum Toxin & HA Dermal Filler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Shanghai Haohai Biological Technology Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Shanghai Haohai Biological Technology Recent Developments
Table 120. Medytox Corporation Information
Table 121. Medytox Description and Major Businesses
Table 122. Medytox Botulinum Toxin & HA Dermal Filler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Medytox Botulinum Toxin & HA Dermal Filler Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Medytox Recent Developments
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Botulinum Toxin & HA Dermal Filler Distributors List
Table 128. Botulinum Toxin & HA Dermal Filler Customers List
Table 129. Botulinum Toxin & HA Dermal Filler Market Trends
Table 130. Botulinum Toxin & HA Dermal Filler Market Drivers
Table 131. Botulinum Toxin & HA Dermal Filler Market Challenges
Table 132. Botulinum Toxin & HA Dermal Filler Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Botulinum Toxin & HA Dermal Filler Product Picture
Figure 3. Global Botulinum Toxin & HA Dermal Filler Market Share by Type in 2021 & 2028
Figure 3. Botulinum Toxin Product Picture
Figure 4. HA Dermal Filler Product Picture
Figure 5. Global Botulinum Toxin & HA Dermal Filler Market Share by Application in 2021 & 2028
Figure 6. Men
Figure 7. Women
Figure 8. Botulinum Toxin & HA Dermal Filler Report Years Considered
Figure 9. Global Botulinum Toxin & HA Dermal Filler Sales 2017-2028 (K Units)
Figure 10. Global Botulinum Toxin & HA Dermal Filler Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Botulinum Toxin & HA Dermal Filler Revenue 2017-2028 (US$ Million)
Figure 12. Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Region (2017-2022)
Figure 14. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Region (2023-2028)
Figure 15. North America Botulinum Toxin & HA Dermal Filler Sales YoY (2017-2028) & (K Units)
Figure 16. North America Botulinum Toxin & HA Dermal Filler Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Botulinum Toxin & HA Dermal Filler Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Botulinum Toxin & HA Dermal Filler Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Botulinum Toxin & HA Dermal Filler Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Botulinum Toxin & HA Dermal Filler Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Botulinum Toxin & HA Dermal Filler Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Botulinum Toxin & HA Dermal Filler Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Botulinum Toxin & HA Dermal Filler Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Botulinum Toxin & HA Dermal Filler Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Botulinum Toxin & HA Dermal Filler Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Botulinum Toxin & HA Dermal Filler in the World: Market Share by Botulinum Toxin & HA Dermal Filler Revenue in 2021
Figure 27. Global Botulinum Toxin & HA Dermal Filler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 29. Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 30. Global Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 31. Global Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 32. North America Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 33. North America Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 34. North America Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 35. North America Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 36. North America Botulinum Toxin & HA Dermal Filler Sales Share by Country (2017-2028)
Figure 37. North America Botulinum Toxin & HA Dermal Filler Revenue Share by Country (2017-2028)
Figure 38. U.S. Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 41. Europe Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 42. Europe Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 43. Europe Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 44. Europe Botulinum Toxin & HA Dermal Filler Sales Share by Country (2017-2028)
Figure 45. Europe Botulinum Toxin & HA Dermal Filler Revenue Share by Country (2017-2028)
Figure 46. Germany Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 47. France Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Botulinum Toxin & HA Dermal Filler Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Botulinum Toxin & HA Dermal Filler Revenue Share by Region (2017-2028)
Figure 57. China Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 60. India Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 68. Latin America Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 70. Latin America Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Botulinum Toxin & HA Dermal Filler Sales Share by Country (2017-2028)
Figure 72. Latin America Botulinum Toxin & HA Dermal Filler Revenue Share by Country (2017-2028)
Figure 73. Mexico Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Botulinum Toxin & HA Dermal Filler Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Botulinum Toxin & HA Dermal Filler Revenue Share by Country (2017-2028)
Figure 82. Turkey Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Botulinum Toxin & HA Dermal Filler Revenue (2017-2028) & (US$ Million)
Figure 85. Botulinum Toxin & HA Dermal Filler Value Chain
Figure 86. Botulinum Toxin & HA Dermal Filler Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---